Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 5/12/2019
SIETES contiene 92850 citas

 
 
<< anterior 21 a 40 de 99 siguiente >>
Presentar resultados
Seleccionar todas
21.Tiene citas relacionadas
Ioannidis JPA, Mulrow CD, Goodman SN. Adverse events: the more you search, the more you find. Ann Intern Med 2006;144:298-300. [Ref.ID 76456]
22.Tiene citas relacionadas Cita con resumen
Bent S, Padula A, Avins AL. Brief communication: better ways to question patients about adverse medical events. A randomized, controlled trial. Ann Intern Med 2006;144:257-61. [Ref.ID 76454]
23. Cita con resumen
Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005;366:1797-803. [Ref.ID 75488]
24.
Ilkhanoff L, Lewis JD, Hennessy S, Berlin JA, Kimmel SE. Potential limitations of electronic database studies of prescription non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs) and risk of myocardial infarction. Pharmacoepidemiol Drug Saf 2005;14:513-22. [Ref.ID 74563]
25. Cita con resumen
Mudge DW, Johnson DW. Coca-Cola and kangaroos. Lancet 2004;364:1190. [Ref.ID 71491]
26. Cita con resumen
Nelson K. Vaccine additives pose little risk to children. Lancet 2003;362:1987. [Ref.ID 68469]
27. Cita con resumen
Senior K. Aspirin withdrawal increases risk of heart problems. Lancet 2003;362:1558. [Ref.ID 68049]
28. Cita con resumen
Gruchalla RS. Clinical assessment of drug-induced disease. Lancet 2000;356:1505-11. [Ref.ID 53693]
29. Cita con resumen
Sturkenboom MC, Romano F, Simon G, Correa Leite ML, Villa M, Nicolosi A, Borgnolo G, Bianchi-Porro G, Mannino S. The shadow costs of NSAID therapy - A population study. Pharmacoepidemiol Drug Saf 2000;9:S137. [Ref.ID 53246]
30. Cita con resumen
Krappweiss JK, Kirch W. NSAID use among outpatients at high risk for adverse drug reactions in a German area. Pharmacoepidemiol Drug Saf 2000;9:S98. [Ref.ID 53229]
31.
Schillevoort I, Herings RMC, Roos R A C, Jansen PAF, Leufkens HGM. Complexity of prior antipsychotic use determines future risk of parkinsonism in patients using risperidone, olanzapine or haloperidol. Pharmacoepidemiol Drug Saf 2000;9:S95. [Ref.ID 53228]
32. Cita con resumen
Kaufman DW, Kelly JP, Anderson TE, Rosenberg L, Mitchell AA. A comprehensive ongoing population-based survey of medication use in the United States - The adult population. Pharmacoepidemiol Drug Saf 2000;9:S60. [Ref.ID 53206]
33. Cita con resumen
Simoni M, Pedreschi M, Baldacci S, Pistelli F, Carrozzi L, Sapigni T, Viegi G. The Po river delta epidemiological study: use of medicines in a general population sample of North Italy. Pharmacoepidemiol Drug Saf 2000;9:319-26. [Ref.ID 53174]
34.
Palop Larrea V, Sempere Verdú E, Martínez-Mir I. Anamnesis farmacológica y reacciones adversas a medicamentos. Aten Primaria 2000;25:666-8. [Ref.ID 51178]
35. Cita con resumen
Dukas L, Willett WC, Colditz GA, Fuchs CS, Rosner B, Giovannucci EL. Prospective study of bowel movement, laxative use, and risk of colorectal cancer among women. Am J Epidemiol 2000;151:958-64. [Ref.ID 51167]
36.
Furlani G, Bacchi C, Giliberto F, Binacchi S, Santi G, Pasini C. Il dolore lombare acuto. Informazioni sui Farmaci 2000;24:43-7. [Ref.ID 50893]
37.Tiene citas relacionadas Cita con resumen
Kennedy JM, van Rij AM, Spears GF, Pettigrew R A, Tucker IG. Polypharmacy in a general surgical unit and consequences of drug withdrawal. Br J Clin Pharmacol 2000;49:353-62. [Ref.ID 50502]
38. Cita con resumen
Cortès X, Soriano JB, Sunyer J, Martínez-Moratalla J, Muniozgoren N, Maldonado JA, Quirós R, Antó JM. Factores asociados al desarrollo de atopia en adultos jóvenes. Med Clin (Barc) 2000;114:165-8. [Ref.ID 49400]
39.
40.
Casanellas JM, Torre P, Rovira M, Gelabert Colomer G, Conesa A, Vilardell L. La història clínica en un nou marc assistencial (social). Annals Med (Barc) 1999;82:341-2. [Ref.ID 48538]
Seleccionar todas
 
<< anterior 21 a 40 de 99 siguiente >>